Biomarkers-based Biosensing and Bioimaging with Graphene for Cancer Diagnosis

We introduce the cancer diagnosis with graphene-based biosensing and bioimaging aiming at detecting cancer biomarkers

Hui Gu; Huiling Tang; Ping Xiong; Zhihua Zhou

2019

Scholarcy highlights

  • Cancer, the second leading cause of death globally, accounts for 8.8 million deaths and possibly over 21 million by 2030
  • Because early discovery of cancer is difficult, almost all the patients are diagnosed with terminal cancer, which is awfully bad for cancer treatment
  • In the past few years, nanodiagnostics including nanomaterial-based biosensing and bioimaging have attracted enormous interest throughout the scientific community because they brought about unparalleled advances in cancer discovery
  • We chose to survey graphene-based biosensing and bioimaging approaches concerning cancer biomarkers recognition in the past few years that could serve as alternative means for early cancer diagnosis
  • We introduce the cancer diagnosis with graphene-based biosensing and bioimaging aiming at detecting cancer biomarkers
  • Other recognition units such as folic acid, Hyaluronic acid, protein, peptides and aptamer have been used to targeted cancer cells imaging in recent years
  • Design of simpler, faster, smaller graphene-based devices for the monitoring of cancer biomarkers is a thriving research and development area which elevates the potential applications graphene in cancer diagnosis

Need more features? Save interactive summary cards to your Scholarcy Library.